≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Benign neoplasm: Nasopharynx

DOID Endpoint Browser PheWeb

CD2_BENIGN_NASOPHARYNX

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — D10.6&
  • Hospital discharge: ICD-9 — 2107
  • Hospital discharge: ICD-8 — 2107
  • Cause of death: ICD-10 — D10.6&
  • Cause of death: ICD-9 — 2107
  • Cause of death: ICD-8 — 2107

2 out of 7 registries used, show all original rules.

312

4. Check minimum number of events

None

312

5. Include endpoints

None

312

6. Filter based on genotype QC (FinnGen only)

312

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
D10
Name in latin
Neoplasma benignum nasopharyngis

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 1716 784 921
Only index persons 1545 733 812
Unadjusted period prevalence (%)
Whole population 0.02 0.02 0.03
Only index persons 0.03 0.03 0.03
Median age at first event (years)
Whole population 52.07 54.78 49.75
Only index persons 51.34 54.20 48.77

-FinnGen-

Key figures

All Female Male
Number of individuals 312 155 157
Unadjusted period prevalence (%) 0.06 0.05 0.07
Median age at first event (years) 56.74 54.98 58.49

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
270
Matched controls
2698
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D10.6
ICD-10 Finland
Benign neoplasm: Nasopharynx
+∞
320.7
240
*
EMA30
NOMESCO Finland
Biopsy of rhinopharynx
376.3
61.0
59
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
15.5
51.1
89
83
EMB30
NOMESCO Finland
Adenotomy
31.1
25.1
33
12
UDQ12
NOMESCO Finland
Flexible laryngoscopy
8.5
18.0
40
54
21070
ICD-8 Finland
Benign neoplasm of buccal cavity and pharynx, Nasopharynx
+∞
16.8
16
*
J35.2
ICD-10 Finland
Hypertrophy of adenoids
25.0
16.7
23
10
DHA10
NOMESCO Finland
Biopsy of cavity of nose
35.8
16.0
20
6
2107A
ICD-9 Finland
Benign neoplasm of lip, oral cavity and pharynx, Nasopharynx
+∞
15.8
15
*
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
12.4
13.6
24
21
ENA10
NOMESCO Finland
Biopsy of pharynx
147.0
13.6
14
*
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
27.4
13.5
18
7
H65.2
ICD-10 Finland
Chronic serous otitis media
21.3
12.6
18
9
R01AD09
ATC
mometasone; nasal
2.5
11.3
133
760
H65.3
ICD-10 Finland
Chronic mucoid otitis media
11.3
11.0
20
19
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
13.9
10.3
17
13
UDC00
NOMESCO Finland
Ear microscopy
4.4
10.2
37
93
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.2
9.2
145
928
1290
FHL
Epipharyngoscopy
92.8
8.5
9
*
ENB00
NOMESCO Finland
Excision or exploration of lesion of pharynx
+∞
8.4
8
*
J34.2
ICD-10 Finland
Deviated nasal septum
5.2
7.8
23
47
H65.0
ICD-10 Finland
Acute serous otitis media
15.6
7.8
12
8
TDA90
NOMESCO Finland
Removal wax from ear
15.6
7.8
12
8
R01AD08
ATC
fluticasone; nasal
2.3
7.7
84
443
WX408
NOMESCO Finland
General anesthesy, balanced
2.2
7.3
91
509
DHB10
NOMESCO Finland
Excision of lesion of internal nose
30.9
7.2
9
*
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
3.0
7.1
40
146
H66.0
ICD-10 Finland
Acute suppurative otitis media
4.0
7.0
27
73
H66.9
ICD-10 Finland
Otitis media, unspecified
4.6
6.9
23
54
R01BA52
ATC
pseudoephedrine, combinations; oral
2.1
6.8
88
499
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
41.1
6.8
8
*
J39.2
ICD-10 Finland
Other diseases of pharynx
12.7
6.6
11
9
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
6.3
67
347
C11.9
ICD-10 Finland
Malignant neoplasm: Nasopharynx, unspecified
+∞
6.3
6
*
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
5.1
6.2
18
37
Z01.1
ICD-10 Finland
Examination of ears and hearing
2.5
6.1
50
225

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
62
234
3.06
12.59
1.4
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
157
993
2.17
10.20
2.6
2.1
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
179
1201
2.15
9.88
7.6
5.9
%
57.8
57.6
0.09
163
1129
(3002030) Lymphocytes/100 leukocytes in Blood
181
1222
2.15
9.80
8.1
6.1
%
27.7
27.5
0.11
164
1139
(3022096) Basophils/100 leukocytes in Blood
172
1148
2.11
9.49
7.9
6.0
%
0.7
0.6
1.02
156
1064
(3006504) Eosinophils/100 leukocytes in Blood
176
1187
2.11
9.42
8.0
6.0
%
2.9
2.8
0.24
159
1100
(3019069) Monocytes/100 leukocytes in Blood
176
1191
2.10
9.29
8.5
6.3
%
8.7
8.5
0.27
160
1115
(42870588) Differential panel, method unspecified - Blood
136
848
2.07
8.83
8.2
5.8
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
184
1316
1.97
7.78
8.2
6.3
e9/l
0.2
0.2
0.67
161
1164
(3019198) Lymphocytes [#/volume] in Blood
183
1311
1.96
7.65
7.5
5.9
e9/l
1.8
1.9
0.73
163
1165
(3006315) Basophils [#/volume] in Blood
179
1277
1.94
7.53
7.6
5.9
e9/l
0.0
0.0
0.92
156
1105
(3001604) Monocytes [#/volume] in Blood
178
1273
1.93
7.37
7.6
5.9
e9/l
0.6
0.6
0.56
155
1099
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
12
21
5.90
6.64
1.4
1.1
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
195
1468
1.88
6.58
11.0
9.8
e9/l
4.1
4.1
0.09
165
1291
(3021879) Hepatitis B virus core Ab [Presence] in Serum
37
163
2.44
5.46
1.2
1.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
108
712
1.79
5.35
4.1
4.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
21
70
3.14
5.21
1.1
1.2
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
71
417
1.91
5.05
2.1
1.9
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
23
83
2.91
5.00
4.6
3.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
146
1065
1.70
4.97
4.7
4.6
g/l
35.1
35.5
0.42
134
1002
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
155
1150
1.69
4.94
5.8
5.8
mmol/l
1.2
1.2
0.06
143
1052
(3042936) Bacteria identified in Isolate by Culture
66
384
1.91
4.82
2.0
1.9
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
68
403
1.88
4.69
3.8
3.5
mmol/l
0.8
0.8
0.16
63
376
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
140
1022
1.67
4.67
2.1
2.0
pmol/l
97.3
95.4
0.16
75
524
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
165
1260
1.66
4.60
7.2
6.5
mmol/l
1.2
1.2
0.10
138
1066
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
227
1885
1.75
4.59
4.6
3.8
pmol/l
14.8
14.7
0.23
209
1698
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
23
88
2.74
4.51
2.3
1.7
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
189
1504
1.65
4.40
5.3
4.8
mmol/l
6.8
6.7
0.26
177
1408
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
11
26
4.35
4.39
1.1
1.5
nmol/l
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
142
1053
1.64
4.38
8.8
9.5
inr
1.3
1.3
0.25
35
328
(3007853) Bacteria identified in Skin by Aerobe culture
53
300
1.92
4.18
2.6
1.7
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
23
94
2.56
3.98
2.6
1.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
205
1701
1.60
3.72
6.1
4.4
—
—
—
0
0
(40758558) Short blood count panel - Blood
92
634
1.64
3.68
9.0
6.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
11
30
3.76
3.67
1.2
1.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
42
230
1.95
3.64
1.8
2.0
nmol/l
312.3
364.1
0.79
36
207
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
91
633
1.62
3.48
2.5
2.3
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
16
58
2.85
3.47
1.3
1.3
—
—
—
0
0
(3012544) pH of Venous blood
42
235
1.91
3.43
2.9
3.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
13
43
3.11
3.29
2.1
3.7
—
—
—
0
0
(3018418) pH of Serum or Plasma
105
765
1.56
3.28
3.4
3.9
ph
7.4
7.4
0.20
22
158
(3013707) Erythrocyte sedimentation rate by Westergren method
221
1894
1.57
3.25
5.9
4.1
mm/h
13.9
12.0
0.99
206
1743
(3023419) Bacteria identified in Sputum by Culture
11
33
3.42
3.22
2.7
2.2
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
11
33
3.42
3.22
1.1
1.4
nmol/l
0.4
0.5
0.30
11
27
(40768795) Lymph node Pathology biopsy report
10
28
3.66
3.22
1.4
1.0
—
—
—
0
0
(4062490)
9
20
4.60
3.13
1.8
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
111
827
1.53
3.11
2.6
2.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
45
266
1.81
3.10
1.4
1.5
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
17
68
2.59
3.10
2.8
3.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
10
30
3.41
2.93
1.0
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
10
30
3.41
2.93
1.3
1.1
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
72
492
1.60
2.92
5.8
3.8
ng/l
851.6
249.6
0.71
56
386
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
28
144
2.04
2.91
1.8
1.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
93
677
1.53
2.87
3.3
2.8
umol/l
323.7
6491.6
2.67
85
582
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
148
1186
1.47
2.85
4.1
4.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
250
2236
1.59
2.75
22.6
15.6
%
39.9
40.1
0.13
172
1594
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
60
2.58
2.74
1.2
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
37
3.05
2.72
1.1
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
47
294
1.70
2.68
2.0
1.9
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
70
485
1.57
2.67
1.7
1.7
nmol/l
1076.0
1225.3
0.63
51
366
(3045414) Leukocytes [Presence] in Urine
20
93
2.23
2.67
2.4
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
57
377
1.63
2.63
1.6
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
17
74
2.37
2.63
2.2
2.4
u/ml
0.3
0.4
0.40
11
36
(3044927) Protein electrophoresis panel - Urine
9
25
3.67
2.59
1.6
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
14
56
2.57
2.57
1.2
1.5
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
224
1968
1.49
2.56
10.0
7.6
u/l
80.0
80.6
0.05
209
1849
(3002256) Pathology report gross observation
49
315
1.66
2.53
1.4
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
51
332
1.64
2.51
4.1
4.8
mmol/l
1.0
1.0
0.44
46
309
(3000991) Gas panel - Venous blood
35
205
1.80
2.50
7.3
7.8
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
26
3.53
2.50
1.4
1.2
—
—
—
0
0
(3013512) EKG study
103
786
1.46
2.48
4.6
3.9
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
76
545
1.52
2.48
1.7
1.8
mg/l
1.0
1.3
0.84
62
425
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
61
419
1.57
2.41
1.6
1.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
46
295
1.66
2.40
1.9
2.0
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
16
71
2.32
2.38
1.6
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
129
1036
1.42
2.34
2.3
2.2
nmol/l
74.6
75.4
0.12
114
914
(3019230) Fractional oxyhemoglobin in Venous blood
10
35
2.92
2.32
4.3
3.2
%
62.9
63.2
—
10
35
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
10
35
2.92
2.32
1.7
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
16
72
2.29
2.32
1.6
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
61
423
1.55
2.31
2.7
2.8
e6/l
0.8
0.9
0.16
36
242
(3021788) Differential panel - Synovial fluid
11
41
2.74
2.30
1.7
1.3
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
49
323
1.61
2.30
1.5
1.6
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
99
761
1.44
2.27
3.9
3.3
mg/l
81.7
139.6
0.29
63
491
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
36
2.84
2.22
1.4
1.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
74
540
1.49
2.21
4.9
4.0
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
30
175
1.79
2.19
1.8
1.8
g/l
1.8
1.4
0.31
25
158
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
16
74
2.22
2.18
1.3
1.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
51
345
1.57
2.15
31.2
21.3
inr
1.4
1.3
—
8
45
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
60
422
1.52
2.13
1.3
1.3
iu/ml
38.7
32.3
0.15
21
146
(3020682) Albumin/Creatinine [Ratio] in Urine
103
808
1.41
2.09
4.9
4.0
mg/mmol
15.2
9.9
0.29
68
513
(3027945) Reticulocytes/100 erythrocytes in Blood
44
291
1.60
2.04
1.9
2.9
%
1.8
1.8
0.23
37
263
(3030467) Casts [#/volume] in Urine by Automated count
91
702
1.42
2.02
3.5
3.1
e6/l
0.2
0.5
1.15
62
528
(3019225) pH of Specimen
39
251
1.63
2.02
4.6
3.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
189
1646
1.38
2.01
3.7
3.3
u/l
46.3
50.6
0.27
180
1545
(3024354) Oxygen [Partial pressure] in Venous blood
32
196
1.70
1.99
2.5
3.3
kpa
4.6
4.3
0.30
32
188
(3017704) Immunofixation for Urine
5
11
4.60
1.95
1.2
1.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
9
33
2.78
1.94
2.6
3.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
6
16
3.80
1.94
1.2
4.9
%
13.2
12.1
—
6
16
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
56
397
1.50
1.92
2.9
3.0
e6/l
3.4
2.0
0.37
32
220
(3001122) Ferritin [Mass/volume] in Serum or Plasma
128
1054
1.36
1.91
2.7
2.6
ug/l
126.2
125.0
0.02
117
960
(3037522) Nuclear Ab [Titer] in Serum
49
338
1.53
1.91
1.4
1.3
titre
510.0
506.8
—
8
79
(3035637) Corticotropin [Mass/volume] in Plasma
7
22
3.23
1.89
1.7
2.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
47
322
1.54
1.89
5.0
4.7
%
30.4
31.8
0.44
31
209
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
8
28
2.90
1.87
1.0
1.2
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
29
176
1.71
1.87
1.7
2.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
46
2.44
1.87
1.6
1.7
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
10
40
2.55
1.85
1.7
1.6
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
32
201
1.66
1.83
3.1
2.8
ml/min/173m2
79.4
63.0
—
10
85
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
12
4.22
1.83
1.6
1.1
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
12
4.22
1.83
1.4
1.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
97
769
1.38
1.82
3.6
3.1
e6/l
19.8
134.7
0.78
71
599
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
9
35
2.62
1.81
1.0
1.1
—
17.4
—
0
8
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
22
124
1.83
1.81
10.9
9.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
12
54
2.27
1.76
1.7
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
138
1161
1.34
1.76
11.5
9.8
e9/l
0.0
0.0
0.57
113
959
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
6
18
3.38
1.75
1.2
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
34
221
1.60
1.71
2.2
3.1
e9/l
72.0
72.3
0.02
26
177
(3018095) Leukocytes [#/volume] in Urine
109
889
1.35
1.70
4.0
3.7
e6/l
28.0
69.1
1.33
77
652
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
20
112
1.84
1.69
4.6
2.9
mmol/l
25.2
24.7
0.40
20
106
(3000494) Fungus identified in Specimen by Culture
46
322
1.50
1.68
1.6
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
33
214
1.61
1.68
3.7
4.2
%
0.8
1.0
0.21
13
67
(3014051) Protein [Presence] in Urine by Test strip
11
49
2.29
1.65
2.3
2.1
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
80
624
1.38
1.64
2.3
2.1
mg/l
2.6
3.2
1.26
63
538
(3002179) Metamyelocytes/100 leukocytes in Blood
30
191
1.63
1.64
3.3
4.1
%
0.6
0.3
—
10
46
(3014765) Yersinia sp identified in Stool by Organism specific culture
15
77
2.00
1.62
1.3
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
15
77
2.00
1.62
1.3
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
14
70
2.05
1.62
1.2
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
98
792
1.35
1.61
2.9
3.1
ng/l
1230.5
1289.4
0.07
88
668
(3009508) Creatinine [Moles/volume] in Urine
100
811
1.34
1.60
3.9
3.2
mmol/l
7.4
7.5
0.07
84
672
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
49
352
1.47
1.59
1.7
2.1
%
20.7
22.4
0.48
42
309
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
14
71
2.02
1.56
1.5
2.8
%
94.9
85.5
0.71
14
65
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
261
2437
1.43
1.56
5.3
4.7
mmol/l
6.1
6.0
0.62
236
2216
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
10
44
2.31
1.55
1.2
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
111
919
1.32
1.54
4.3
3.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
99
807
1.33
1.53
2.7
2.5
u/l
58.7
54.9
0.46
90
747
(3028433) Virus identified in Specimen by Culture
5
15
3.37
1.53
1.0
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
15
3.37
1.53
1.2
1.2
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
62
469
1.40
1.52
3.1
3.1
mmol/l
2.5
2.5
0.22
52
417
(3000492) Spirometry study
35
238
1.53
1.47
1.5
1.5
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
28
2.53
1.46
1.0
1.1
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
104
860
1.31
1.44
3.2
3.3
mmol/l
2.4
2.4
0.09
86
749
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
22
2.76
1.44
1.2
1.1
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
17
96
1.82
1.42
2.1
2.2
ug/l
153.4
375.2
1.64
17
89
(3014576) Chloride [Moles/volume] in Serum or Plasma
45
326
1.44
1.40
6.3
6.7
mmol/l
103.9
104.0
0.03
45
319
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
22
135
1.68
1.40
1.4
1.3
—
35.7
—
0
8
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
54
405
1.40
1.40
1.4
1.3
u/ml
37.6
12.4
0.59
12
158
(4146454)
7
29
2.45
1.40
4.3
2.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
30
200
1.55
1.38
5.6
3.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
46
336
1.43
1.38
1.2
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
17
2.97
1.36
1.6
1.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
29
193
1.55
1.35
3.3
4.4
%
0.2
0.1
0.11
11
56
(3026008) Bacteria identified in Urine by Culture
93
765
1.31
1.33
3.6
3.1
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
264
2489
1.39
1.31
22.1
14.7
mg/l
22.1
23.7
0.37
232
1987
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
69
1.92
1.30
1.6
1.6
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
65
509
1.35
1.30
2.0
1.4
g/l
2.3
2.6
0.63
40
303
(3039443) Prostate specific Ag panel - Serum or Plasma
11
55
2.04
1.29
2.1
1.5
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
39
280
1.45
1.28
9.2
7.5
mmol/l
1.3
1.4
0.04
30
228
(40768443) Skin Pathology biopsy report
19
115
1.69
1.28
1.3
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
14
77
1.86
1.27
1.4
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
21
131
1.65
1.27
3.9
3.9
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
8
36
2.25
1.25
1.5
1.5
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
25
2.43
1.25
1.2
1.1
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
83
679
1.30
1.23
3.4
3.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
13
71
1.87
1.21
2.5
2.5
ug/min
82.9
78.4
—
8
41
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
245
2294
1.32
1.19
6.1
4.6
mu/l
1.9
2.5
0.58
228
2081
(3044889) 12 lead EKG panel
195
1775
1.26
1.19
4.6
4.0
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
31
217
1.48
1.17
7.3
7.0
mmol/l
1.8
1.3
0.81
31
209
(3023511) Choriogonadotropin [Units/volume] in Urine
0
34
0.00
1.16
0.0
1.1
—
—
—
0
0
(3026782) Osmolality of Urine
64
509
1.32
1.16
3.2
2.7
mosm/kgh2o
531.5
562.5
0.52
54
435
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
35
0.00
1.16
0.0
1.5
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
36
0.00
1.14
0.0
1.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
11
58
1.93
1.13
1.0
1.2
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
28
194
1.49
1.11
2.4
3.2
ng/l
74.2
79.1
0.19
23
172
(3004616) Nuclear Ab [Presence] in Serum
7
31
2.29
1.11
1.0
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
5
21
2.40
1.09
3.6
2.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
32
2.21
1.08
4.1
3.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
273
2607
1.38
1.07
18.9
13.8
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
7
33
2.15
1.06
1.4
1.9
pg
32.7
33.4
—
7
33
(3019060) Gas panel - Arterial blood
24
163
1.51
1.05
5.7
4.6
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
12
68
1.80
1.02
2.0
1.7
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
25
173
1.48
1.01
5.2
2.7
kpa
5.2
5.2
0.08
25
160
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
38
285
1.38
1.01
3.5
4.3
ug/l
3.2
47.7
0.96
31
237
(44790048)
7
35
2.02
1.00
1.3
1.8
—
—
—
0
0
(44806118)
7
35
2.02
1.00
1.3
1.8
—
—
—
0
0
(44790049)
7
35
2.02
1.00
1.3
1.8
—
—
—
0
0
(44790047)
7
35
2.02
1.00
1.3
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
169
1533
1.22
0.99
3.6
3.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
23
157
1.50
0.99
1.3
1.4
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
18
116
1.59
0.99
1.3
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
23
2.19
0.98
1.8
1.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
5
23
2.19
0.98
2.2
1.7
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
36
1.97
0.97
1.6
1.8
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
36
1.97
0.97
1.7
1.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
20
133
1.54
0.97
4.8
2.5
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
17
109
1.59
0.95
2.9
2.9
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
26
184
1.45
0.95
3.5
4.4
%
0.0
0.2
—
10
46
(3027456) Digoxin [Moles/volume] in Serum or Plasma
7
37
1.91
0.94
5.1
3.1
nmol/l
0.8
0.9
—
7
31
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
265
2532
1.31
0.93
5.6
5.1
mmol/l
2.6
2.7
1.08
238
2318
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
29
211
1.41
0.92
3.7
3.7
mmol/l
1.2
1.2
0.55
29
192
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
28
2.16
0.92
2.5
3.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
115
1012
1.22
0.89
4.3
3.9
ng/l
27.3
42.0
1.26
86
731
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
248
2356
1.26
0.87
7.4
6.1
mmol/mol
41.0
40.3
0.52
230
2186
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
23
162
1.45
0.87
6.5
6.3
mmol/l
23.6
24.9
0.75
23
162
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
6
31
1.95
0.85
1.7
1.9
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
6
31
1.95
0.85
1.2
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
10
57
1.78
0.84
1.4
1.4
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
72
607
1.24
0.84
1.6
1.6
nmol/l
20.2
21.2
0.25
59
506
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
46
1.76
0.83
1.5
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
40
314
1.31
0.82
11.6
7.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
81
695
1.22
0.80
1.7
1.7
mmol/l
1.5
1.4
0.32
60
568
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
15
98
1.56
0.80
1.5
1.9
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
9
54
1.69
0.75
2.7
4.0
—
—
—
0
0
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
5
24
2.10
0.75
2.2
1.6
e6/l
972.2
532.7
—
5
19
(3000850) Epithelial cells [#/volume] in Urine
64
540
1.23
0.74
3.2
2.5
e6/l
3.7
4.7
0.74
52
479
(3020564) Creatinine [Moles/volume] in Serum or Plasma
275
2657
1.30
0.74
24.7
17.2
umol/l
78.9
77.8
0.27
275
2657
(3048689) Calprotectin [Mass/mass] in Stool
36
283
1.31
0.74
2.5
2.1
ug/g
138.3
135.7
0.02
29
226
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
25
2.02
0.73
2.0
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
25
2.02
0.73
2.0
1.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
25
2.02
0.73
2.0
1.8
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
11
68
1.64
0.72
1.1
1.1
—
13.6
—
0
8
(3041096) Erythrocytes [Presence] in Urine by Automated
60
706
0.81
0.72
3.8
3.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
251
2404
1.23
0.71
4.5
4.1
mmol/l
1.3
1.3
0.36
221
2195
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
26
1.94
0.71
1.0
1.2
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
26
1.94
0.71
1.4
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
26
1.94
0.71
1.0
1.1
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
89
781
1.20
0.70
2.2
2.2
u/l
147.7
211.5
1.08
84
738
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
21
153
1.40
0.69
1.1
1.2
iu/ml
31.7
141.6
—
7
61
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
27
1.87
0.68
2.2
2.6
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
5
27
1.87
0.68
1.4
1.6
—
—
—
0
0
(3022621) pH of Urine by Test strip
22
163
1.38
0.66
4.3
2.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
67
576
1.21
0.66
5.6
4.8
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
65
558
1.21
0.65
1.7
1.7
pmol/l
128571919.0
432.8
0.49
49
466
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
23
173
1.36
0.64
1.7
1.5
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
15
104
1.46
0.63
1.1
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
19
139
1.39
0.62
1.7
1.2
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
33
264
1.28
0.61
1.8
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
72
1.55
0.60
2.1
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
8
53
1.52
0.59
1.9
1.5
—
—
—
0
0
(3020891) Body temperature
15
106
1.44
0.59
3.8
4.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
37
1.63
0.56
3.0
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
12
82
1.48
0.55
1.2
1.7
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
38
1.59
0.54
1.2
1.3
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
6
39
1.55
0.53
1.3
1.7
%
84.4
90.0
—
6
39
(3044941) Cell count panel - Synovial fluid
6
39
1.55
0.53
1.7
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
24
188
1.30
0.53
2.5
2.8
e9/l
3.7
3.9
0.21
19
151
(3003694) ABO and Rh group [Type] in Blood
75
666
1.17
0.52
1.3
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
11
75
1.48
0.51
2.0
2.6
mg/l
8.8
13.1
1.61
11
70
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
10
67
1.51
0.50
1.1
1.2
—
3.4
—
0
10
(40761536) Microorganisms panel - Urine sediment
18
233
0.76
0.49
5.1
3.4
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
274
2671
1.21
0.49
14.7
10.6
u/l
24.6
26.0
0.99
262
2579
(3023103) Potassium [Moles/volume] in Serum or Plasma
266
2587
1.19
0.48
25.6
16.9
mmol/l
4.0
4.0
0.34
260
2523
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
255
2472
1.17
0.48
5.1
4.6
mmol/l
1.4
1.5
0.65
229
2261
(3019150) Specific gravity of Urine by Refractometry
60
527
1.17
0.48
5.7
4.3
kg/l
1.0
1.0
—
10
73
(3044290) Cell count panel - Cerebral spinal fluid
7
47
1.50
0.48
1.3
1.6
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
256
2483
1.17
0.47
5.1
4.6
mmol/l
4.5
4.6
0.72
230
2292
(21494755) Public health laboratory ask at order entry panel
16
209
0.75
0.46
1.6
1.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
59
520
1.17
0.45
3.2
2.9
ug/l
0.8
0.8
0.18
39
329
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
50
1.41
0.45
1.6
1.9
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
10
69
1.46
0.45
1.1
1.2
—
8.7
—
0
13
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
62
550
1.16
0.44
1.4
1.3
u/ml
0.9
1.3
0.59
11
146
(1761482) Bacteria [#/volume] in Urine by Culture
11
78
1.43
0.43
4.4
5.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
29
241
1.22
0.42
2.4
2.4
ug/l
6.9
7.8
0.14
29
207
(3014271) Vancomycin [Susceptibility]
0
15
0.00
0.41
0.0
2.4
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(4010399)
23
187
1.25
0.40
1.3
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
10
71
1.42
0.39
1.5
1.3
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
124
1.31
0.39
2.5
2.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
5
35
1.44
0.39
1.4
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
5
35
1.44
0.39
1.4
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
5
37
1.36
0.37
1.6
1.5
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
132
1243
1.11
0.37
5.2
3.8
estimate
0.0
0.0
0.00
14
240
(3029937) Albumin [Presence] in Urine by Test strip
61
675
0.88
0.36
6.0
4.1
estimate
0.0
0.0
0.00
17
244
(3033705) Calcium.ionized [Moles/volume] in Venous blood
6
41
1.47
0.36
2.5
2.9
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
41
1.47
0.36
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
41
1.47
0.36
1.5
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
41
1.47
0.36
1.5
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
41
1.47
0.36
1.5
1.4
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
14
108
1.31
0.36
2.4
1.6
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
6
43
1.40
0.35
1.7
1.7
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
283
2781
1.19
0.35
30.9
21.6
e9/l
6.8
6.7
0.27
277
2705
(3021601) Nitrite [Presence] in Urine by Test strip
130
1226
1.10
0.35
6.5
5.1
estimate
0.0
0.0
0.00
17
246
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
10
73
1.38
0.35
2.6
3.3
—
1.3
—
0
8
(3022145) Colonoscopy Study observation
33
285
1.18
0.34
1.3
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
6
47
1.28
0.32
4.7
3.3
e9/l
3.1
4.3
—
6
47
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
245
2390
1.12
0.31
20.4
13.6
ml/min/173m2
79.6
80.2
0.19
216
1984
(36660697) Celiac disease serology panel - Serum
22
184
1.21
0.31
1.4
1.2
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
55
1.28
0.30
1.0
1.2
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
8
63
1.28
0.28
4.8
2.2
kpa
7.8
8.1
—
8
56
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
91
969
0.91
0.27
5.3
3.9
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
128
1219
1.08
0.27
5.0
3.8
estimate
0.0
0.0
0.00
17
252
(3003327) Ova and parasites identified in Stool by Light microscopy
10
78
1.29
0.24
1.9
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
6
82
0.73
0.24
1.2
1.8
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
6
83
0.72
0.24
1.2
2.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
6
83
0.72
0.24
1.2
2.3
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
6
83
0.72
0.24
1.2
2.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
5
42
1.19
0.21
6.2
2.1
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
11
0.00
0.21
0.0
1.1
—
6.4
—
0
11
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
0
10
0.00
0.21
0.0
1.3
—
5653.4
—
0
5
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
10
0.00
0.21
0.0
3.9
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
10
0.00
0.21
0.0
3.9
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
12
0.00
0.21
0.0
2.4
—
103.1
—
0
12
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
19
219
0.86
0.21
2.4
2.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
23
202
1.15
0.21
2.0
1.8
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
94
894
1.07
0.20
5.3
4.9
ug/l
3.9
2.7
0.42
81
797
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
48
1.25
0.20
1.2
1.3
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
6
49
1.23
0.20
6.5
3.5
%
57.3
56.9
—
6
49
(3050129) First trimester maternal screen panel - Serum or Plasma
6
49
1.23
0.20
1.8
1.5
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
6
51
1.18
0.19
2.0
2.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
51
1.18
0.19
1.2
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
53
1.13
0.19
1.5
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
16
138
1.17
0.18
1.5
1.5
—
—
—
0
0
(3027315) Oxygen [Partial pressure] in Blood
8
70
1.15
0.16
8.5
2.7
kpa
8.7
8.2
—
8
70
(3013290) Carbon dioxide [Partial pressure] in Blood
8
70
1.15
0.16
8.5
2.7
kpa
4.6
5.0
—
8
70
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
75
714
1.07
0.16
4.2
4.4
%
23.3
21.4
0.62
40
332
(3016879) Cocaine [Presence] in Urine
6
78
0.76
0.15
1.0
2.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
18
200
0.89
0.13
2.2
1.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
10
85
1.18
0.12
2.8
2.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
34
317
1.08
0.12
1.2
1.4
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
5
48
1.04
0.09
1.2
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
6
54
1.11
0.09
1.3
3.8
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
64
0.78
0.08
1.0
1.5
—
—
—
0
0
(4094501)
7
65
1.08
0.08
1.1
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
67
1.05
0.08
3.1
2.0
—
—
—
0
0
(40768793) Breast Pathology biopsy report
6
72
0.83
0.07
1.7
1.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
11
99
1.12
0.06
1.3
1.1
—
—
—
0
0
(1002224) Polysomnography panel
12
109
1.10
0.06
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
23
217
1.06
0.06
1.5
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
15
140
1.08
0.04
1.4
1.2
—
—
—
0
0
(4034850)
10
91
1.10
0.04
17.0
8.9
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
19
180
1.06
0.04
2.1
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
11
119
0.92
0.04
1.1
1.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
92
914
1.01
0.00
3.5
3.0
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
29
285
1.02
0.00
4.2
3.6
—
—
—
0
0
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
0
5
0.00
0.00
0.0
1.6
—
24.4
—
0
5
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
2.2
—
1.3
—
0
6
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
7
0.00
0.00
0.0
2.1
—
—
—
0
0
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
147.5
—
0
6
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
1.8
—
0
5
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
5
0.00
0.00
0.0
2.0
—
88.0
—
0
5
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3024471) HLA-A [Type]
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
7
0.00
0.00
0.0
2.6
—
116.9
—
0
7
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035509) Tobramycin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.8
—
1.1
—
0
5
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
6.0
—
0
5
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
69
0.87
0.00
1.0
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
49
1.02
0.00
1.0
2.9
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
3.0
—
—
—
0
0
(3010421) pH of Blood
8
81
0.99
0.00
8.5
2.6
ph
7.4
7.4
—
8
70
(1001926) Buprenorphine [Presence] in Urine by Screen method
6
67
0.89
0.00
1.0
2.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
7
73
0.96
0.00
1.6
1.5
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
6
69
0.87
0.00
1.3
1.7
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_NASOPHARYNX and mortality.

Females

Parameter HR [95% CI] p-value
CD2_BENIGN_NASOPHARYNX 1.468 [1.14, 1.89] 0.003
Birth year 0.988 [0.98, 1.0] 0.01

During the follow-up period (1.1.1998 — 31.12.2019), 99 out of 608 females with CD2_BENIGN_NASOPHARYNX died.

Males

Parameter HR [95% CI] p-value
CD2_BENIGN_NASOPHARYNX 1.524 [1.23, 1.89] < 0.001
Birth year 0.985 [0.98, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 145 out of 638 males with CD2_BENIGN_NASOPHARYNX died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_NASOPHARYNX.

N-year risk Females Males
1 0.144% 0.226%
5 0.644% 1.578%
10 1.517% 4.198%
15 2.925% 8.015%
20 5.201% 13.646%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_NASOPHARYNX – Benign neoplasm: Nasopharynx

GWS hits: 2

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data